A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of RXI-109 in reducing the
recurrence of hypertrophic scar formation following elective revision of a pre-existing
hypertrophic scar.